Management of dyslipidemia in children and adolescents with diabetes

scientific article

Management of dyslipidemia in children and adolescents with diabetes is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.2337/DIACARE.26.7.2194
P698PubMed publication ID12832334

P50authorAmerican Diabetes AssociationQ4743610
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectdyslipidemiaQ66291209
teenagerQ1492760
P304page(s)2194-2197
P577publication date2003-07-01
P1433published inDiabetes CareQ5270111
P1476titleManagement of dyslipidemia in children and adolescents with diabetes
P478volume26

Reverse relations

cites work (P2860)
Q36360053A 5-Year Follow-up Study to Assess Clinical Outcomes of Patients with Diabetes Undergoing Lower Limb Angiography for Significant Peripheral Artery Disease
Q38426319A Wireless Diabetes Management and Communication System
Q43552894A pediatric perspective: adult problems in kids, new challenges in pediatric diabetes
Q50895252A possible Fourier transform infrared-based plasma fingerprint of angiotensin-converting enzyme inhibitor-induced reversal of endothelial dysfunction in diabetic mice.
Q37463043A questionnaire for determining prevalence of diabetes related foot disease (Q-DFD): construction and validation
Q37875776A review of the Eurodiale studies: what lessons for diabetic foot care?
Q34781467Adiposity and β-cell function: relationships differ with ethnicity and age
Q34781491Age‐Related Changes in Insulin Sensitivity and β‐Cell Function Among European‐American and African‐American Women
Q47793526An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers
Q39435263Antidiabetic Activity of a Lotus Leaf Selenium (Se)-Polysaccharide in Rats with Gestational Diabetes Mellitus
Q43123588Antidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats
Q34356596Applicability of the ankle-brachial-index measurement as screening device for high cardiovascular risk: an observational study.
Q35971662Approach to lipid screening as a risk marker for cardiovascular disease in pediatric patients with diabetes
Q46716554Are there advantages with U-Albumin/U-Creatinine ratios compared with U-Albumin in monitoring diabetes?
Q28166699Aspirin therapy in type 2 diabetes in a general practice in Italy
Q34239673Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.
Q35723697Atherosclerosis screening by noninvasive imaging for cardiovascular prevention: a systematic review
Q36357072Atypical leg symptoms: does routine measurement of the ankle brachial pressure index (ABPI) in primary care benefit patients?
Q47992562Audit of the dietetic care of patients with type 1 diabetes at a large Australian paediatric tertiary hospital and comparison with the International Society for Paediatric and Adolescent Diabetes nutrition guidelines.
Q44295787Blockade of the renin-angiotensin system in African Americans with hypertension and cardiovascular disease
Q40061300Can first-trimester screening program detect women at high risk for gestational diabetes mellitus?
Q40174992Can the metabolic syndrome identify children with insulin resistance?
Q35984594Cardiovascular complications in pediatric end-stage renal disease
Q27009400Cardiovascular disease in children and adolescents with diabetes: where are we, and where are we going?
Q36679572Cardiovascular disease risk in youth with diabetes mellitus
Q46701536Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres
Q79233367Cardiovascular risk factors in adolescents
Q35060841Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes
Q37920503Characteristics of peripheral arterial disease and its relevance to the diabetic population
Q51122703Chemiluminescence lateral flow immunoassay cartridge with integrated amorphous silicon photosensors array for human serum albumin detection in urine samples.
Q54158544Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension.
Q36359500Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension
Q51464123Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus.
Q37234346Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation
Q46707992Comparison of insulin detemir and insulin glargine in subjects with Type 1 diabetes using intensive insulin therapy
Q35752772Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes
Q44564244Creating a combination antihypertensive regimen: what does the research show?
Q37982207Current approaches to the treatment of hypertension in older persons
Q80603574Determination of glycated hemoglobin in clinically silent hemoglobin variants
Q36772146Diabetes care, glycemic control, complications, and concomitant autoimmune diseases in children with type 1 diabetes in Turkey: a multicenter study.
Q51746953Diabetes mellitus concurrent with hepatic haemosiderosis in two macaws (Ara severa, Ara militaris).
Q44371155Diabetes mellitus in middle-aged people is associated with increased sick leave: the BELSTRESS study
Q47569895Diabetes self-management experience: a focus group study of Taiwanese patients with type 2 diabetes.
Q30428895Diabetes-associated macrovascular complications: cell-based therapy a new tool?
Q33696622Diabetes: cost of illness in Norway
Q35983217Diabetic management in high risk patients (pregnancy, insulin pumps).
Q36973440Diabetic nephropathy in children and adolescents
Q81090368Diabetic nephropathy-an evaluation of potential risk factors in young patients with type 1 diabetes mellitus
Q44534132Diabetic population mortality and cardiovascular risk attributable to hypertension: a decade follow-up from the Tehran Lipid and Glucose Study.
Q34357233Diagnosis and treatment of diabetic foot infections
Q37322411Duodenal–Jejunal Bypass Surgery Does Not Increase Skeletal Muscle Insulin Signal Transduction or Glucose Disposal in Goto–Kakizaki Type 2 Diabetic Rats
Q38873062Dyslipidaemia and hypertension among adults with diabetes in rural Uganda
Q35576079Dyslipidemia in Patients with Type 2 Diabetes. Relationships between Lipids, Kidney Disease and Cardiovascular Disease
Q37067611Dyslipidemia in children with type 2 diabetes vs. obesity
Q36977819Dyslipidemia in youth with diabetes: to treat or not to treat?
Q59279847Early atherosclerosis in childhood type 1 diabetes: role of raised systolic blood pressure in the absence of dyslipidaemia
Q33858320Effect of sarpogrelate treatment on the prognosis after endovascular therapy for critical limb ischemia
Q44953752Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen
Q57274310Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
Q50887228Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service.
Q34078199Epidemiology of type 1 diabetes
Q40585117Epidemiology, treatment and costs of depression in adults with Type 2 diabetes
Q38241744Executive function, adherence, and glycemic control in adolescents with type 1 diabetes: a literature review
Q33373177Exercise training in the aerobic/anaerobic metabolic transition prevents glucose intolerance in alloxan-treated rats
Q35226524Factors associated with higher oxytocin requirements in labor
Q44945901Factors related to nephrotic-range proteinuria in late-stage chronic kidney disease patients with diabetes mellitus
Q28220294Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review
Q34155197Gender differences in diabetes-related lower extremity amputations
Q31111951Genetic random effects model for family data with long-term survivors: analysis of diabetic nephropathy in type 1 diabetes
Q33249944Glucose testing and insufficient follow-up of abnormal results: a cohort study
Q46790318Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress.
Q35183768Glycemic control, complications, and associated autoimmune diseases in children and adolescents with type 1 diabetes in Jeddah, Saudi Arabia
Q46049651Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry
Q35576082Haemoglobin A1c – A Marker for Complications of Type 2 Diabetes: The Experience from the UK Prospective Diabetes Study (UKPDS)
Q44035730Health literacy, complication awareness, and diabetic control in patients with type 2 diabetes mellitus
Q35974034Hypertension and microalbuminuria: the new detrimental duo.
Q46032481Hypertensive retinopathy: incidence, risk factors, and comorbidities.
Q41235361Impact of chromium dinicocysteinate supplementation on inflammation, oxidative stress, and insulin resistance in type 2 diabetic subjects: an exploratory analysis of a randomized, double-blind, placebo-controlled study
Q33819061Impact of initial active engagement in self-monitoring with a telemonitoring device on glycemic control among patients with type 2 diabetes
Q46758013Improved glycaemic control of thrice-daily biphasic insulin aspart compared with twice-daily biphasic human insulin; a randomized, open-label trial in patients with type 1 or type 2 diabetes
Q46973573Increased sucrose intake is not associated with a change in glucose or insulin sensitivity in people with type 2 diabetes
Q36609772Insulin aspart: a review
Q51470730Insulin resistance and inflammation - A further systemic complication of COPD.
Q36918012Insulin: a model system for nanomedicine?
Q35053417Intrauterine exposure to diabetes is a determinant of hemoglobin A(1)c and systolic blood pressure in pima Indian children
Q35614502Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial.
Q36392685Is the development of diabetes with antihypertensive therapy a problem?--Pro
Q36768104Less favorable body composition and adipokines in South Asians compared with other US ethnic groups: results from the MASALA and MESA studies
Q35127306Levels of brain natriuretic peptide are associated with peripheral arterial disease in subjects with type-2 diabetes mellitus
Q51245364Lipid Profile in Relation to Glycemic Control in Type 1 Diabetes Children and Adolescents in Bangladesh.
Q37105165Lipid and lipoprotein profiles in youth with and without type 1 diabetes: the SEARCH for Diabetes in Youth case-control study
Q84218627Lipid profile and nutritional intake in children and adolescents with Type 1 diabetes improve after a structured dietician training to a Mediterranean-style diet
Q40513962Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease
Q37857087Macrovascular angiopathy in children and adolescents with type 1 diabetes.
Q41669506Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus
Q34620649Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy
Q37292261Management of pediatric and adolescent type 2 diabetes
Q36392677Management strategies for patients with hypertension and diabetes: why combination therapy is critical
Q35886386Managing high-risk patients with hypertension: focus on the renin-angiotensin system
Q45265388Metabolic syndrome and the older male population
Q35686501Microalbuminuria in type 2 diabetics: an important, overlooked cardiovascular risk factor
Q45325691Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease
Q34557730Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines
Q51534526Neonatal respiratory morbidity in late-preterm births in pregnancies with and without gestational diabetes mellitus.
Q51982689Nurses' perceived and actual level of diabetes mellitus knowledge: results of a cluster analysis.
Q37435331Nutrition evidence-based guidelines for treating hyperlipidemia in children with type 1 diabetes: a case presentation.
Q36938575Nutritional management in childhood and adolescent diabetes
Q34543079Obesity, Glucose Intolerance and Diabetes and Their Links to Cardiovascular Disease. Implications for Laboratory Medicine
Q22252954Obesity: Genetic, molecular, and environmental aspects
Q36565874Outcomes from a diabetes self-management intervention for Native Hawaiians and Pacific People: Partners in Care
Q42272320PED/PEA-15 controls fibroblast motility and wound closure by ERK1/2-dependent mechanisms
Q33683628Pediatric endocrinologists' management of children with type 2 diabetes
Q35963263Peer chart audits: a tool to meet Accreditation Council on Graduate Medical Education (ACGME) competency in practice-based learning and improvement
Q28198594Perceived discrimination and use of preventive health services
Q37910796Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who?
Q42634108Perspectives of patients with type 2 diabetes following a critical cardiac event - an interpretative approach
Q41008029Pharmaceutical care of adolescents with diabetes mellitus type 1: the DIADEMA study, a randomized controlled trial
Q31142279Physical activity in adults with and without diabetes: from the 'high-risk' approach to the 'population-based' approach of prevention.
Q50986939Physiological effects of ultrasound mist on fibroblasts.
Q42931796Plasma C-peptide level is inversely associated with family history of type 2 diabetes in Korean type 2 diabetic patients
Q44417715Postprandial glucose, insulin and gastrointestinal hormones in healthy and diabetic subjects fed a fructose-free and resistant starch type IV-enriched enteral formula
Q36199074Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peers
Q40362789Predictors of Dyslipidemia Over Time in Youth With Type 1 Diabetes: For the SEARCH for Diabetes in Youth Study
Q24799963Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study
Q36494412Prevalence and determinants of elevated apolipoprotein B and dense low-density lipoprotein in youths with type 1 and type 2 diabetes
Q33317048Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates
Q37113661Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes
Q39786811Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases.
Q50556773Relationship between glycated hemoglobin A1c and cognitive function in nondemented elderly patients with type 2 diabetes.
Q44248315Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.
Q46208453Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus
Q36219240Risk factors of peripheral arterial disease: a case control study in Sri Lanka
Q43420221Screening for gestational diabetes in the 21st century: a population-based cohort study in Israel
Q53811490Selenoprotein P is not elevated in gestational diabetes mellitus.
Q39723407Self-perceptions on the impact of diabetes among working adults: insights into disability prevention
Q35176887Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
Q35046826Serum lipid profiles and glycemic control in adolescents and young adults with type 1 diabetes mellitus
Q35741754Slowing cardiovascular disease progression in African-American patients: diabetes management
Q38917838State transition model: vorapaxar added to standard antiplatelet therapy to prevent thrombosis post myocardial infarction or peripheral artery disease
Q36123467Stroke in patients with diabetes and hypertension
Q46102618Sugar profiles and soluble and insoluble dietary fiber contents of fruits in Thailand markets
Q47193897Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene.
Q36283702Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient
Q38030808Targeting hypertension in patients with cardiorenal metabolic syndrome.
Q43263706The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management task
Q40970747The association between skeletal maturation and adrenal androgen levels in obese children and adolescents.
Q33889993The burden of physical activity on type 2 diabetes public healthcare expenditures among adults: a retrospective study
Q30409221The challenges and future considerations regarding pregnancy-related outcomes in women with pre-existing diabetes
Q49712339The contribution of family history to the burden of diagnosed diabetes, undiagnosed diabetes, and prediabetes in the United States: analysis of the National Health and Nutrition Examination Survey, 2009-2014.
Q37095574The economic burden of cancer in Korea in 2002.
Q46583591The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
Q38424292The emerging global epidemic of type 1 diabetes
Q91979476The relation of serum nesfatin-1 level with anthropometric and metabolic parameters in children and adolescents: A prospective observational study
Q38705802The relationship between diabetes, diabetes-related complications and productive activities among older Europeans
Q25255077The relationship between obesity, hyperglycemia symptoms, and health-related quality of life among Hispanic and non-Hispanic white children and adolescents
Q33393473Three years follow-up of screen-detected diabetic and non-diabetic subjects: who is better off? The ADDITION Netherlands study
Q48209542Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
Q95816149Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents
Q36783749Treatment of type 2 diabetes in youth
Q33585122Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers
Q37595136Type 2 diabetes in the pediatric population: Are we meeting ADA clinical guidelines in Ohio?
Q82048576Type 2 diabetes mellitus in children and adolescents
Q46926231Undocumented immigration status and diabetes care among Mexican immigrants in two immigration "sanctuary" areas
Q43168054Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients
Q45057356Why is self-monitoring reimbursed for blood glucose but not blood pressure?
Q82861408[Lipid profile and anthropometrical evaluation in type 1 diabetes]
Q36947018beta-cell function and anti-diabetic pharmacotherapy

Search more.